ADXN Stock Analysis: Buy, Sell, or Hold?
ADXN - Addex Therapeutics Ltd American Depositary Shares
$6.25
-0.20 (-3.10%)
▼
5d:
+0.64%
30d:
-10.71%
90d:
+5.93%
HOLD
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Jun 15, 2026
0d
Get Alerted When ADXN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ADXN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ADXN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ADXN is currently trading at $6.25, which is considered slightly low relative to its 30-day fair value range of $6.19 to $6.81.
Technical Outlook: Technically, ADXN is in a downtrend. Immediate support is located at $5.61, while resistance sits at $7.27. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: ADXN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $30.00 (+365.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ADXN is in a downtrend. Immediate support is located at $5.61, while resistance sits at $7.27. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: ADXN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $30.00 (+365.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$6.19 -
$6.81
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading 365.1% below Wall St target ($30.00)
Trading Range Analysis
30-Day Trading Range
$6.19 -
$6.81
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$5.61
Resistance Level
$7.27
Current Trend
Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Wall Street Target
$30.00
(+365.1%)
Revenue Growth (YoY)
949.7%
Share & Embed Analysis
Last updated: June 24, 2026 1:51 PM ET
Data refreshes hourly during market hours. Next update: 2:51 PM
Data refreshes hourly during market hours. Next update: 2:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADXN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 53 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 61 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 58 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 61 BUY |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$38 | 58 HOLD |
